25 results for “Molecular Targeted Therapy”. Showing 25 of 39,449.
Antitumour immunity regulated by aberrant ERBB family signalling.
molecular-targeted therapies. Although cancer immunotherapies, including immune checkpoint inhibitors
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations.
targeted therapies in lung cancer with driver molecular alterations. Targeted
Gemtuzumab Ozogamicin in Acute Myeloid Leukemia: Efficacy, Toxicity, and Resistance Mechanisms-A Systematic Review.
targeted therapies that may allow for improved antileukemic effects while reducing toxicity significantly. Gemtuzumab ozogamicin (GO) is one of the most thoroughly studied molecularly
Targeting the EGFR signalling pathway in metastatic colorectal cancer.
molecularly targeted therapies is inescapably limited by the insurgence of mechanisms
Targeted and molecular therapies in Ewing sarcoma: a comprehensive review of preclinical and clinical advances.
Targeted and molecular therapies in EWS show significant promise, particularly
Progress in the treatment of advanced gastric cancer.
molecular-targeted therapy, and immunotherapy. In this article, we summarize
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
molecular-targeted therapies against GBM. Other strategies, such as nanodelivery
Treatment of Pediatric Low-Grade Gliomas.
molecular targeted therapy (BRAF inhibitors and/or MEK inhibitors) in the recurrent
PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.
clinical trials, and serve as biomarkers for targeted molecular therapies.
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
molecularly targeted therapies, demands flexible and comprehensive approaches to profile
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
molecular targeted therapy in the clinical trial setting. Germline or somatic
NK cells for cancer immunotherapy.
molecularly targeted therapies. These observations, in addition to the capacity
Pten signaling in gliomas.
opens up new perspectives for a targeted molecular therapy of malignant gliomas.
Hair disorders in patients with cancer.
molecularly targeted therapies, immunotherapies, radiotherapy, stem cell transplants, and endocrine
BRAF - a tumour-agnostic drug target with lineage-specific dependencies.
with BRAF-mutant cancers who benefit from molecularly targeted therapies.
Molecular biology exploration and targeted therapy strategy of Ameloblastoma.
molecular biology advances, and targeted therapy. RESULTS: Among the 156 articles
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.
molecular mechanism of HCC occurrence is key to seeking effective targeted therapy
Redefining Treatment Paradigms in Thyroid Eye Disease: Current and Future Therapeutic Strategies.
therapies targeting core molecular pathways involved in TED. Results: Current
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.
molecular targets for therapy. Serial Analysis of Gene Expression (SAGE
Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function.
molecular targets of therapies to correct apoE4-associated mitochondrial dysfunction
-
molecular genetic testing. Targeted therapies: Dietary treatment includes protein restriction
Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.
molecular biology, targeted biological therapy for malignant tumors has gradually
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
indicate new potential molecular targets for the therapy of this disease.
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer.
molecular targets for cancer therapy. LAY SUMMARY: We employed single
Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson's Disease.
molecular chaperones, gene therapy targeting SNCA, and DNA aptamers are some